XAF1 as a modifier of p53 function and cancer susceptibility
Emília M. Pinto(St. Jude Children's Research Hospital), Michael R. Clay(University of Colorado Anschutz Medical Campus), Tatiana EI-Jaick B. Costa(Hospital Infantil Joana de Gusmão), Tobias Else(University of Michigan), Ana Cláudia Latronico(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Dominique Vaur(Centre François Baclesse), Sharon A. Savage(National Cancer Institute), Berenice B. Mendonça(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Ivy Z.S. Parise(Instituto de Tecnologia do Paraná), Mariana M. Paraizo(Instituto de Tecnologia do Paraná), Madson Q. Almeida(Universidade de São Paulo), Evadnie Rampersaud, Moara Machado(National Cancer Institute), Payal P. Klincha(National Cancer Institute), Guillermo Chantada(Hospital Sant Joan de Déu Barcelona), Elena M. Stoffel(University of Michigan), Kristine Jones(Leidos (United States)), Emerson Wander Silva Soares(Santa Casa Hospital), Kelvin C. de Andrade(National Cancer Institute), Alberto S. Pappo(St. Jude Children's Research Hospital), Luiz Paulo Kowalski(Translational Research in Oncology), Karina Miranda Santiago(AC Camargo Hospital), Cinzia Lavarino, Wenan Chen(St. Jude Children's Research Hospital), Kara N. Maxwell(Philadelphia VA Medical Center), Maria Candida Barisson Villares Fragoso(Instituto do Câncer do Estado de São Paulo), Gabriela Trindade Felix(Universidade Federal da Bahia), Carolina Mathias(Yahoo (Spain)), Edenir Inêz Palmero(DASA (Brazil)), Weiyin Zhou(Leidos (United States)), Vicente Odone Filho(Instituto do Câncer do Estado de São Paulo), Heloísa Komechen(Instituto de Tecnologia do Paraná), Bonald C. Figueiredo(Instituto de Tecnologia do Paraná), Camila Matzenbacher Bittar(Universidade Federal do Rio Grande do Sul), Éric Letouzé(Centre National de la Recherche Scientifique), Kayla V. Hamilton(St. Jude Children's Research Hospital), Sáhlua Miguel Volc(Hospital de Câncer de Barretos), Patrícia Ashton‐Prolla(Universidade Federal do Rio Grande do Sul), Maria Isabel Achatz(Hospital Sírio-Libanês), Vania Balderrama-Brondani(Universidade de São Paulo), Maria Nirvana Formiga(AC Camargo Hospital), Aurélie Vogt(National Cancer Institute), Cíntia Regina Niederauer Ramos(Hospital de Câncer de Barretos), Jinling Wang(Beihua University), Meredith Yeager(Frederick National Laboratory for Cancer Research), Enilze M.S.F. Ribeiro(Universidade Federal do Paraná), José Luis Fuster‐Soler(Hospital Universitario Virgen de la Arrixaca), Henrique C.R. Galvão(Hospital de Câncer de Barretos), Laurence Brugières(Institut Gustave Roussy)
Cited by 58
Related Papers
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|998